Key Metrics
CiteScore 

1
SNIP 

0.28
Recommended pre-submission checks
Powered by 

Farmakoekonomika Journal Specifications
| Overview | |
| Publisher | IRBIS LLC |
| Language | Russian |
| Article Processing Charges | RUB 15000 |
| Publication Time | 8 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Russian |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Copyright Notice |
| License type | CC BY-NC-SA |
| OA statement | Visit website |
View less
Planning to publish in Farmakoekonomika ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Farmakoekonomika
Chemoreactomic analysis of magnesium- and vitamin B6-depleting drugs within the Anatomical Therapeutic Chemical classification as a basis for preventing adverse effects of pharmacotherapy
- 27 Apr 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Pharmacoeconomic evaluation of contemporary treatment, prevention, and screening strategies for melanoma: a review of evidence and implications for the Russian healthcare system
- 3 Mar 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
A method for evaluating diagnostic effectiveness using algorithms based on opinion obtained from artificial intelligence models
- 12 Feb 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Features of population consumption of combined glucose-lowering drugs in pharmacy organizations of the Russian Federation
- 11 Feb 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Studying the risks of drug provision for breast cancer patients in the public procurement system of Russia
- 9 Feb 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Clinical and economic assessment of an extended release lanreotide formulation (Somatuline® Autogel®) in patients with gastrointestinal neuroendocrine tumors
- 22 Jan 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Chemoreactomic analysis of magnesium- and vitamin B6-depleting drugs within the Anatomical Therapeutic Chemical classification as a basis for preventing adverse effects of pharmacotherapy
- 27 Apr 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Pharmacoeconomic evaluation of contemporary treatment, prevention, and screening strategies for melanoma: a review of evidence and implications for the Russian healthcare system
- 3 Mar 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
A method for evaluating diagnostic effectiveness using algorithms based on opinion obtained from artificial intelligence models
- 12 Feb 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Features of population consumption of combined glucose-lowering drugs in pharmacy organizations of the Russian Federation
- 11 Feb 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Studying the risks of drug provision for breast cancer patients in the public procurement system of Russia
- 9 Feb 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Clinical and economic assessment of an extended release lanreotide formulation (Somatuline® Autogel®) in patients with gastrointestinal neuroendocrine tumors
- 22 Jan 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology